The current focus on banning menthol cigarettes raises questions about personal versus collective responsibility.
India has recorded a record tally of new 314,835 COVID-19 cases over the past 24 hours with hospitals running out of oxygen, medicine and beds.
In order to prevent COVID-19 turning serious and requiring hospital treatment, the UK government has recently announced a new task-force, which will develop new drugs to save the life of persons with mild coronavirus symptoms.
All pandemics end. There is maybe only cold comfort in that while still enduring one, but there is some comfort in it just the same.
Surely one of the key lessons of the pandemic is the value of research and development, which in turn means the value of making the investments over time in education and equipment so that researchers are tooled up and ready to go as needed.
The development of a COVID-19 digital health passport is one of the hottest debates right now.
The introduction of new applications of digital technology such as the internet of things (IoT), artificial intelligence (AI) and blockchain promises to be the spark that triggers the mainstream adoption and propagation of precision medicine.